Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



These 2 Stocks Will Move the Dow Tomorrow

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

As the month comes to a close, the height of earnings season is just about over. But that doesn't mean that you should stop paying attention, because sometimes, the last ones to the party bring the most exciting news.

Tomorrow, two more members of the Dow Jones Industrials (INDEX: ^DJI  ) will give us their spin on how the economy has affected their businesses and what they see for their future. With the markets anxiously awaiting news from Europe and wanting signs of economic strength, what these companies say could make or break the Dow's performance for a lot longer than just tomorrow.

Let's take a closer look at the companies that are issuing earnings reports tomorrow.

ExxonMobil (NYSE: XOM  )
Big Oil giant ExxonMobil reports tomorrow, and analysts see the company extending its streak of quarterly earnings growth to eight straight reports. Investors expect to see the company post $1.95 per share in earnings, up from $1.85 per share a year ago. Yet Chevron (NYSE: CVX  ) missed estimates last week on weakness in its refinery operations. That has some wondering if Exxon could follow suit and miss as well.

It's easy to focus solely on headline numbers like Exxon's huge revenues, which have been well above $100 billion in every quarter so far for 2011. Bear in mind that sales and profits are well off 2008's record highs, which came during oil's run to almost $150 per barrel before its monumental collapse. But in the long run, it's probably better to see Exxon post consistent numbers even if they're slightly lower than those record levels.

Pfizer (NYSE: PFE  )
Pharma stocks aren't seeing the same growth as the rest of the market, and Pfizer is no exception. Analyst estimates call for the pharma bellwether to have earned $0.47 per share, flat from a year ago.

What you should look at more closely, though, is how the company does now that Lipitor has come off patent. The company is doing its best to maintain sales of the hit drug, cutting prices on name-brand Lipitor. Moreover, with only limited competition from Watson Pharmaceuticals (NYSE: WPI  ) and Ranbaxy Labs for the first six months, Pfizer won't feel the full impact yet. But whatever impact it does have should give shareholders a clue of what's to come.

Make a strong finish
Even as companies post their earnings, don't tune out on your stocks. News happens between quarterly reports as well, and often it's that news that makes stocks move the most.

But keep in mind -- there are plenty of other companies out there that investors need to watch during this earnings season. In the Fool's "Fourth-Quarter Earnings Report: 7 Stocks You'll Want to Watch," you'll find information on this quarter's possible big performers. It's completely free for our readers, so click here to access your free report today.

Fool contributor Dan Caplinger stays in motion. You can follow him on Twitter here. He doesn't own shares of the companies mentioned in this article. Motley Fool newsletter services have recommended buying shares of Pfizer and Chevron. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy tells it like it is.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1768792, ~/Articles/ArticleHandler.aspx, 10/22/2016 2:26:53 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 17 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:47 PM
^DJI $18145.71 Down -16.64 -0.09%
AGN $230.47 Down -2.61 -1.12%
Allergan CAPS Rating: ****
CVX $101.30 Down -0.57 -0.56%
Chevron CAPS Rating: ****
PFE $32.18 Down -0.36 -1.11%
Pfizer CAPS Rating: ****
XOM $86.62 Down -0.59 -0.68%
ExxonMobil CAPS Rating: ****